Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$30.66 - $39.48 $919,800 - $1.18 Million
-30,000 Reduced 20.0%
120,000 $3.87 Million
Q4 2022

Feb 13, 2023

BUY
$22.29 - $35.34 $557,250 - $883,500
25,000 Added 20.0%
150,000 $4.85 Million
Q3 2022

Nov 14, 2022

BUY
$21.92 - $29.19 $1.1 Million - $1.46 Million
50,000 Added 66.67%
125,000 $3.42 Million
Q2 2022

Aug 12, 2022

SELL
$13.72 - $30.31 $576,240 - $1.27 Million
-42,000 Reduced 35.9%
75,000 $1.88 Million
Q1 2022

May 13, 2022

SELL
$23.5 - $42.96 $151,927 - $277,736
-6,465 Reduced 5.24%
117,000 $3.08 Million
Q3 2021

Nov 12, 2021

SELL
$60.65 - $72.12 $8.28 Million - $9.85 Million
-136,535 Reduced 52.51%
123,465 $7.62 Million
Q2 2021

Aug 13, 2021

BUY
$43.51 - $61.94 $8.7 Million - $12.4 Million
200,000 Added 333.33%
260,000 $15.9 Million
Q1 2021

May 14, 2021

BUY
$50.85 - $80.61 $3.05 Million - $4.84 Million
60,000 New
60,000 $3.13 Million

Others Institutions Holding PHR

About Phreesia, Inc.


  • Ticker PHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 52,532,200
  • Market Cap $973M
  • Description
  • Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a ra...
More about PHR
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.